1. Home
  2. BNR vs MYND Comparison

BNR vs MYND Comparison

Compare BNR & MYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • MYND
  • Stock Information
  • Founded
  • BNR 2014
  • MYND 1998
  • Country
  • BNR China
  • MYND Cayman Islands
  • Employees
  • BNR N/A
  • MYND N/A
  • Industry
  • BNR Medical Specialities
  • MYND Other Consumer Services
  • Sector
  • BNR Health Care
  • MYND Real Estate
  • Exchange
  • BNR Nasdaq
  • MYND Nasdaq
  • Market Cap
  • BNR 61.7M
  • MYND 62.3M
  • IPO Year
  • BNR 2020
  • MYND 2017
  • Fundamental
  • Price
  • BNR $5.66
  • MYND $1.15
  • Analyst Decision
  • BNR
  • MYND
  • Analyst Count
  • BNR 0
  • MYND 0
  • Target Price
  • BNR N/A
  • MYND N/A
  • AVG Volume (30 Days)
  • BNR 5.3K
  • MYND 32.8K
  • Earning Date
  • BNR 03-27-2025
  • MYND 03-18-2025
  • Dividend Yield
  • BNR N/A
  • MYND N/A
  • EPS Growth
  • BNR N/A
  • MYND N/A
  • EPS
  • BNR N/A
  • MYND N/A
  • Revenue
  • BNR $72,832,704.00
  • MYND $357,050,000.00
  • Revenue This Year
  • BNR $52.90
  • MYND N/A
  • Revenue Next Year
  • BNR $48.35
  • MYND N/A
  • P/E Ratio
  • BNR N/A
  • MYND N/A
  • Revenue Growth
  • BNR N/A
  • MYND N/A
  • 52 Week Low
  • BNR $0.57
  • MYND $0.01
  • 52 Week High
  • BNR $8.99
  • MYND $5.12
  • Technical
  • Relative Strength Index (RSI)
  • BNR 40.71
  • MYND 43.78
  • Support Level
  • BNR $4.41
  • MYND $1.01
  • Resistance Level
  • BNR $6.33
  • MYND $1.20
  • Average True Range (ATR)
  • BNR 0.54
  • MYND 0.09
  • MACD
  • BNR -0.16
  • MYND 0.03
  • Stochastic Oscillator
  • BNR 35.82
  • MYND 48.28

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more.

Share on Social Networks: